John Jed Kennedy Power - 30 Aug 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Issuer symbol
CNMD
Transactions as of
30 Aug 2021
Net transactions value
-$373,313
Form type
4
Filing time
31 Aug 2021, 17:13:12 UTC
Previous filing
30 Aug 2021
Next filing
04 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $152,625 +3,640 +49% $41.93 11,015 30 Aug 2021 Direct
transaction CNMD Common Stock Sale $490,490 -3,640 -33% $134.75 7,375 30 Aug 2021 Direct F1
transaction CNMD Common Stock Options Exercise $17,988 +300 +4.1% $59.96 7,675 30 Aug 2021 Direct
transaction CNMD Common Stock Sale $40,425 -300 -3.9% $134.75 7,375 30 Aug 2021 Direct
transaction CNMD Common Stock Options Exercise $7,876 +100 +1.4% $78.76 7,475 30 Aug 2021 Direct
transaction CNMD Common Stock Sale $13,475 -100 -1.3% $134.75 7,375 30 Aug 2021 Direct
transaction CNMD Common Stock Options Exercise $19,538 +200 +2.7% $97.69 7,575 30 Aug 2021 Direct
transaction CNMD Common Stock Sale $26,950 -200 -2.6% $134.75 7,375 30 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3,640 -38% $0.000000 5,862 30 Aug 2021 Common Stock 3,640 $41.93 Direct F2
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -300 -1.9% $0.000000 15,900 30 Aug 2021 Common Stock 300 $59.96 Direct F2
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -100 -1.3% $0.000000 7,500 30 Aug 2021 Common Stock 100 $78.76 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -200 -2.1% $0.000000 9,300 30 Aug 2021 Common Stock 200 $97.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F3 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period